Not every cancer responds the same to a given treatment, and it is poorly understood why some patients relapse and others do not. The identification of new biomarkers in patient tissues and biopsy samples will help clinicians predict survival and response to treatment, thus personalizing a patient’s care and saving them from enduring treatments that will not cure their disease. The Privette Vinnedge laboratory collaborates with many medical and surgical oncologists and pathologists at the UC Health, including Dr. Trisha Wise-Draper, to collect and analyze patient samples for the identification of new biomarkers and disease signatures in order to better inform clinical practice.
Figure 1 - Click for caption and to enlarge.
Figure 1 - Vials of plasma from cancer patients and healthy controls are stored prior to analysis for the identification of biomarkers of disease.